# Correction: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer

**Authors:** Lijuan Chen, Pengju Wang, Carmela Di Gioia, Ming Yuan, Zhe Zhang, Jinxin Miao, Wenli Yan, Guanghao Zhao, Yangyang Jia, Na Wang, Zhongxian Zhang, Haoran Guo, Giulia Marelli, Louisa Chard Dunmall, Nicholas R. Lemoine, Yaohe Wang

PMC · DOI: 10.3389/fimmu.2026.1812288 · Frontiers in Immunology · 2026-03-04

## Full-text entities

- **Genes:** IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}
- **Diseases:** lung cancer (MESH:D008175)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Orthopoxvirus vaccinia (species) [taxon 10245]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12997778/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12997778/full.md

---
Source: https://tomesphere.com/paper/PMC12997778